抗MPO ANCA相关性血管炎中支气管扩张高患病率并与独特疾病表现相关
该回顾性研究纳入2005-2015年南特大学医院随访的58例ANCA阳性GPA或MPA患者,胸部高分辨率CT按Feischner学会标准判读。支气管扩张见于22例(37.9%),全部为抗MPO-ANCA阳性;多因素分析显示支气管扩张与抗MPO-ANCA、女性及AAV诊断年龄独立相关。抗MPO ANCA患者中,伴支气管扩张者外周神经受累更常见(54.5% vs 17.6%,p=0.019)、肾脏受累更少(40.9% vs 82.3%,p=0.009),疾病病程、生存及严重肺部感染风险相似。
要点
- 抗MPO-ANCA阳性AAV患者中支气管扩张患病率为37.9%(22/58)。
- 抗MPO ANCA伴支气管扩张者外周神经受累54.5% vs 17.6%(p=0.019)。
- 抗MPO ANCA伴支气管扩张者肾脏受累40.9% vs 82.3%(p=0.009)。
核心结论
- 支气管扩张是白种人抗MPO AAV患者中高患病率的既存呼吸系统疾病,该亚组呈现独特表现。
- 需进一步研究以确认这些发现并阐明该关联的临床意义。
- 呼吸道是否为抗MPO自身免疫启动部位尚待研究。
研究设计与样本
- 回顾性研究,纳入2005-2015年南特大学医院随访的ANCA相关性血管炎患者。
- 共58例,MPA 30例(51.7%)、GPA 28例(48.3%)。
- 两位对临床数据设盲的放射科医师按Feischner学会标准判读胸部高分辨率CT。
主要发现
- AAV诊断中位年龄65.5岁。
- 抗MPO-ANCA阳性39例(67.2%),抗PR3-ANCA阳性19例(32.8%)。
- 支气管扩张见于22例(37.9%),全部为抗MPO-ANCA阳性。
- 多因素分析中支气管扩张与抗MPO-ANCA、女性及AAV诊断年龄独立相关。
- 抗MPO ANCA患者中,伴支气管扩张者外周神经受累54.5% vs 17.6%(p=0.019),肾脏受累40.9% vs 82.3%(p=0.009)。
关键数值与推荐
- 支气管扩张判定依据Feischner学会胸部高分辨率CT标准。
- 抗MPO ANCA患者伴与不伴支气管扩张者疾病病程、生存及严重肺部感染风险相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出需进一步研究以确认这些发现并阐明该关联的临床意义。
- 原文指出呼吸道是否为抗MPO自身免疫启动部位尚待研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the prevalence of bronchiectasis in a Western cohort with ANCA-positive granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) and its correlations with disease presentation and outcome. METHODS: Retrospective study of ANCA-associated vasculitis (AAV) patients followed at Nantes University Hospital (2005-2015). Clinical, biological, and follow-up data were collected through chart review. Two experienced radiologists blinded to the clinical data interpreted chest high-resolution CTs according to the Feischner Society criteria. RESULTS: Fifty-eight patients were included: 30 had MPA (51.7%) and 28 had GPA (48.3%). The median age at AAV diagnosis was 65.5 years. Anti-MPO-ANCA and anti-PR3-ANCA were present in 39 (67.2%) and 19 (32.8%) patients, respectively. Overall, bronchiectasis was found in 22 patients (37.9%), all of whom had anti-MPO ANCA. In multivariate analysis, bronchiectasis was independently associated with anti-MPO-ANCA, female gender and age at AAV diagnosis. Furthermore, anti-MPO ANCA patients with bronchiectasis had more frequent peripheral nerve involvement (54.5 vs. 17.6%, p = 0.019) and less frequent renal involvement than those without bronchiectasis (40.9% vs. 82.3%, p = 0.009). Disease course, survival and risk of severe pulmonary infection were similar in patients with and without bronchiectasis on chest CT. CONCLUSIONS: This study shows that bronchiectasis is a highly prevalent pre-existing respiratory condition in Caucasian patients with anti-MPO AAV. This subset of patients exhibits a distinct presentation. Further studies are needed to confirm these findings and clarify the clinical implications of this association. Whether the respiratory tract could be the site of initiation of anti-MPO auto-immunity remains to be investigated.
引用
- Néel A, Espitia-Thibault A, Arrigoni PP, et al. Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation. Semin Arthritis Rheum. 2017. PMID: 29336783. doi:10.1016/j.semarthrit.2017.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。